Warning: The NCBI web site requires JavaScript to function. more...
Department of Pediatrics, University of Connecticut School of Medicine, and Connecticut Children's Medical Center, Hartford, Connecticut, USA.
We present the first documented case of overdose from xylazine inhalation. The patient developed findings consistent with alpha 2 adrenergic agonist toxicity, eg coma, miosis, apnea, bradycardia, hypothermia, and dry mouth 2 hours after exposure. Standard dose naloxone did not reverse these effects. The patient fully recovered after appropriate supportive measures. A review of prior reports of xylazine exposure is provided.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on